CoChat
Cited by 108

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Endocannabinoid System Components: Overview and Tissue Distribution

Joshi, Neal, Onaivi, Emmanuel S. · 2019 · Advances in Experimental Medicine and Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-3-030-21737-2_1

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 60

  1. Mechoulam R, Gaoni Y (1967) Recent advances in the chemistry of hashish. Fortschr Chem Org Naturst 25:175–213
  2. Mechoulam R, Parker L (2013) Towards a better cannabis drug. Br J Pharmacol 170:1361–1364 · DOI
  3. Uhl GR, Ishiguro H, Onaivi ES, Zhang PW, Akinshola BE, Lin Z et al (2006) Molecular neurobiological methods in marijuana-cannabinoid research. In: Onaivi ES (ed) Methods in molecular medicine: marijuana and cannabinoid research: methods and protocols. Humana Press, Totowa, pp 1–17
  4. O’Brien CP (2006) Preface. In: Onaivi ES, Sugiura T, Di Marzo V (eds) Endocannabinoids: the brain and body’s marijuana and beyond. Taylor and Francis, Boca Raton
  5. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al (1992) Isolation and brain structure of a brain constituents that binds to the cannabinoid receptor. Science 258:1946–1949 · DOI · Paper page
  6. Onaivi ES, Ishiguro H, Gu S, Liu QR (2012) CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity. J Psychopharmacol 26:92–103 · DOI · Paper page
  7. Di Marzo V, Stella N, Zimmer A (2015) Endocannabinoid signaling and deteriorating brain. Nat Rev Neurosci 16:3042 · DOI · Paper page
  8. A report of the National Academies of Sciences, Engineering, Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. The National Academies Press, Washington, DC, 2017
  9. Spiller KJ, Bi GH, He Y, Galaj E, Gardner EL, Xi Z-X (2019) Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats. Br J Pharmacol 176:1268–1281 · DOI
  10. Piotrowska Z, Niezgoda M, Lebkowski W, Filipek A, Domian N, Kasacka I (2018) Sex differences in distribution of cannabinoid receptors (CB1 and CB2), S100A6 and CacyBP/SIP in human aging hearts. Bio Sex Differences. https://doi.org/10.1186/s13293-018-0209-3 · DOI
  11. Sterin-Borda L, Del Zar CF, Borda E (2005) Differential CB1 and CB2 cannabinoid receptor-ionotropic response of rat isolated atria: endogenous signal transduction pathways. Biochem Pharmacol 69:1705–1713 · DOI
  12. Li Q, Guo HC, Maslov LN, Qiao XW, Zhou JJ, Zhang Y (2014) Mitochondrial permeability transition pore plays a role in the cardioprotection of CB2 receptor against ischemia-reperfusion injury. Can J Physiol Pharmacol 92:205–214 · DOI
  13. Hebert-Chatelain E, Marsicano G, Desprez T (2017) Cannabinoids and mitochondria. In: Melis M (ed) Endocannabinoids and lipid mediators in brain functions. Springer, Cham, pp 211–235 · DOI
  14. Brusco A, Tagliaferro P, Saez T, Onaivi ES (2008) Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 62:944–949 · DOI · Paper page
  15. Brusco A, Tagliaferro PA, Saez T, Onaivi ES (2008) Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann N Y Acad Sci 1139:450–457 · DOI · Paper page
  16. Ong WY, Mackie K (1999) A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord. J Neurocytol 28:39–45 · DOI
  17. Castaneda JT, Harui A, Roth MD (2017) Regulation of cell surface CB2 receptor during human B cell activation and differentiation. J NeuroImmune Pharmacol 12:544–554 · DOI
  18. Fede C, Albertin G, Petrelli L, Sfriso MM, Biz C, De Caro R et al (2016) Expression of the endocannabinoid receptors in human fascial tissue. Eur J Histchemistry 60:2643
  19. Galligan JJ (2009) Cannabinoid signaling in the enteric nervous system. Neurogastroenterol Motil 21:899–902 · DOI
  20. Stander S, Schmelz M, Metze D, Luger T, Rukwied R (2005) Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci 38:177–188 · DOI · Paper page
  21. Maccarrone M, Bab I, Biro T, Cabral GA, Dey SK, Di Marzo V et al (2015) Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci 36:277–295 · DOI · Paper page
  22. Toth KF, Adam D, Biro T, Olah A (2019) Cannabinoid signaling in the skin: therapeutic potential of the “C(ut)annabinoid” system. Molecules 24:918. https://doi.org/10.3390/molecules24050918 · DOI · Paper page
  23. del Rio C, Millan E, Garcia V, Appendino G, DeMessa J, Munoz E (2018) The endocannabinoid system of the skin. A potential approach for treatment of skin disorders. Biochem Pharmacol 157:122–133 · DOI
  24. Dustin H, Marks BS, Friedman A (2018) The therapeutic potential of cannabinoids in dermatology. Kin Therapy Lett 23:1–5
  25. Maida V, Corban J (2017) Topical medical cannabis: a new treatment for wound pain – three cases of Pyoderma Gangrenosum. J Pain Symptom Manag 54:732–737 · DOI
  26. Mounessa JS, Siegel JA, Dunnick CA, Dellavalle RP (2017) The role of cannabinoids in dermatology. J Am Acad Dermatol 77:188–190 · DOI
  27. Hashim PW, Cohen JL, Pomei DT, Goldenberg G (2017) Topical cannabinoids in dermatology. Cutis 100:50–52
  28. Olah A, Biro T (2017) Targeting cutaneous cannabinoid signaling in inflammation – a “HIGH” – way to heal? EBioMedicine 16:3–5 · DOI
  29. Van Waes V, Beverley J, Siman H, Tseng KY, Steiner H (2012) CB1 cannabinoid receptor expression in the striatum: association with corticostriatal circuits and developmental regulation. Front Pharmacol 3:21. https://doi.org/10.3389/fphar.2012.00021 · DOI
  30. Hurley MJ, Mash DC, Jenner P (2003) Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain. J Neural Transm 110:1279–1288 · DOI
  31. Gonzalez-Mariscal I, Krzysik-Walker SM, Doyle ME, Liu QR, Cimbro R, Calyo SSC et al (2016) Human CB1 receptor isoforms, present in hepatocytes and B-cells, are involved in regulating metabolism. Scientific Reports 6:33302 · DOI
  32. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Taglaiferro PA, Brusco A et al (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071:10–23 · DOI · Paper page
  33. Zhang HY, Bi GH, Li X, Li J, Qu H, Zhang SJ et al (2015) Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats. Neuropsychopharmacology 40:1037–1051 · DOI
  34. Liu QR, Huang NS, Qu H, O’Connell JF, Gonzalez-Mariscal I, Santa-Cruz-Calvo S et al (2018) Identification of novel mouse and rat isoforms and in silco modeling of human CB1R for peripheral cannabinoid therapeutics. Acta Pharmacol Sin 0:1–11. https://doi.org/10.1038/s41401-018-0152-1 · DOI
  35. Ortega-Gutierrez S, Lopez-Rodriguez ML (2005) CB1 and CB2 cannabinoid receptor binding studies based on meodelling and mutagenesis approaches. Min-Rev Med Chem 5:651–658 · doi:10.2174/1389557054368754
  36. Onaivi ES (2006) Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 54:231–246 · DOI · Paper page
  37. Liu QR, Canseco-Alba A, Zhang HY, Taglaiferro P, Chung M, Dennis E et al (2017) Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. Sci Rep 7:17410 · DOI · Paper page
  38. Onaivi ES, Ishiguro H, Liu QR (2015) Future perspectives: cannabinoid CB2 receptor ligands and their therapeutic potential in mental diseases. In: Fattore L (ed) Cannabinoids in neurological and mental disease, pp 425–444 · DOI
  39. Ndong C, O’Donnell D, Ahmad S, Groblewski T (2011) Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor. Eur J Pharmacol 669:24–31 · DOI
  40. Zhang PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D et al (2004) Human cannabinoid receptor 1:5 exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry 9:916–931 · DOI · Paper page
  41. Sipe JC, Arbour N, Gerber A, Beutler E (2005) Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol 78:231–238 · DOI
  42. Karsak M, Cohen-Solal M, Freudenberg J, Ostertag A, Morieux C, Kornak U et al (2005) Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet 14:3389–3396 · DOI · Paper page
  43. Ishiguro H, Carpio O, Horiuchi Y, Shu A, Higuchi S, Schanz N et al (2010) A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands. Synapse 64:92–96 · DOI
  44. Ishiguro H, Horiuchi Y, Ishikawa M, Koga M, Imai K, Suzuki Y et al (2010) Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry 67:974–982 · DOI · Paper page
  45. Ishiguro H, Iwasaki S, Teasenfitz L, Higuchi S, Horiuchi Y, Saito T et al (2007) Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharm J 7:380–385
  46. Iwasaki S, Ishiguro H, Higuchi S, Onaivi ES, Arinami T (2007) Association study between alcoholism and endocannabinoid metabolic enzyme genes encoding fatty acid amide hydrolase and monglyceride lipase in a Japanese population. Psychat Genet 17:215–220 · DOI
  47. Onaivi ES, Ishiguro H, Gong J, Patel S, Perchuk A, Meozzi PA et al (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074:514–536 · DOI · Paper page
  48. Murphy WJ, Eizirik E, Johnson WE, Zhang YP, Ryder OA, O’Brien SJ (2001) Molecular phylogenetics and the origins of placental mammals. Nature 409:614–814 · DOI · Paper page
  49. Vasileiou I, Fotopoulou G, Matzourani M, Patsouris E, Theocharis S (2013) Evidence for the involvement of cannabinoid receptor’s polymorphisms in the pathophysiology of human diseases. Expert Opin Ther Targets 17:363–377 · DOI
  50. Liu QR, Pan CH, Hishimotor A, Li CY, Xi ZX, Llorente-Berzal A et al (2009) Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav:519–530 · DOI · Paper page
  51. Atwood BK (2010) Mackie k. CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 160:467–479 · DOI · Paper page
  52. Rogers N (2015) Cannabinoid receptor with an ‘identity crisis’ gets a second look. Mat Med 21:966–967
  53. Stempel AV, Stumpf A, Zhang HY, Ozdogan T, Pannasch U, Theis AK (2016) Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus. Neuron 90:795–809 · DOI · Paper page
  54. Onaivi ES, Chaudhuri G, Abaci AS, Parker M, Manier DH, Martin PR (1999) Expression of cannabinoid receptors and their gene transcripts in human blood cells. Prog Neuro-Psychopharmacol Bio Psychiat 23:1063–1077 · DOI
  55. Onaivi ES (2010) Endocannabinoid system, pharmacogenomics and response to therapy. Pharmacogenomics 11:907–910 · doi:10.2217/pgs.10.91
  56. Laurikainen H, Tuominen L, Tikka M, Merisaari H, Armio RL, Sormunen E et al (2019) Sex difference in brain CB1 receptor availability in man. NeuroImage 184:834–842 · DOI
  57. Piotrowska Z, Niezgoda M, Lebkowski W, Filipek A, Domian N, Kasacka I (2018) Sex differences in distribution of cannabinoid receptors (CB1 and CB2), S100A6 and CacyBP/SP in human ageing hearts. Biol Sex Differ 9:50 · DOI
  58. Schlienz NJ, Budney AJ, Lee DC, Vandrey R (2017) Cannabis withdrawal: a review of neurobiological mechanisms and sex differences. Curr Addict Reports 4:75–81 · DOI
  59. Rubino T, Realini N, Guidali C, Braida D, Capurro V, Castiglioni C et al (2008) Chronic d9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adults: behavioral and biochemical correlates. Neuropsychopharmacology 33:2760 · DOI · Paper page
  60. Farquhar CE, Breivogel CS, Gamage TF, Gay EA, Thomas BF, Craft RM et al (2019) Sex, THC, and hormones: Effects on density and sensitivity of CB1 cannabinoid receptors. Drug Alcohol Depend 194:20–27 · DOI

Cited by

See all 108

Metadata

Authors
Joshi, N., & Onaivi, E. S.
Venue
Advances in Experimental Medicine and Biology
Published
2019
Pages
1-12
ISSN
  • 0065-2598
  • 2214-8019
Cited by
108
References
8
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.